MAP2K4

Dual-specificity mitogen-activated protein kinase kinase 4 is an enzyme that in humans is encoded by the MAP2K4 gene.

MAP2K4
Available structures
PDBOrtholog search: PDBe RCSB
Identifiers
AliasesMAP2K4, JNKK, JNKK1, MAPKK4, MEK4, MKK4, PRKMK4, SAPKK-1, SAPKK1, SEK1, SERK1, SKK1, mitogen-activated protein kinase kinase 4
External IDsOMIM: 601335 MGI: 1346869 HomoloGene: 48159 GeneCards: MAP2K4
Orthologs
SpeciesHumanMouse
Entrez

6416

26398

Ensembl

ENSG00000065559

ENSMUSG00000033352

UniProt

P45985

P47809

RefSeq (mRNA)

NM_001281435
NM_003010

RefSeq (protein)

NP_001268364
NP_003001

Location (UCSC)Chr 17: 12.02 – 12.14 MbChr 11: 65.58 – 65.68 Mb
PubMed search
Wikidata
View/Edit HumanView/Edit Mouse

MAP2K4 encodes a dual-specificity kinase that belongs to the Ser/Thr protein kinase family. MAP2K4 phosphorylates MAP kinases in response to various environmental stresses or mitogenic stimuli. MAPK8/JNK1, MAPK9/JNK2, and MAPK14/p38 are substrates for MAP2K4, but MAPK1/ERK2 and MAPK3/ERK1 are not phosphorylated by MAP2K4. Structurally, MAP2K4 contains a kinase domain that is phosphorylated and activated by MAP3K1(aka MEKK1). MAP2K4 contains multiple amino acid sites that are phosphorylated and ubiquitinated. Genetic studies using Map2k4 knockout mice revealed embryonic lethality, impaired hepatogenesis and defective liver formation. Analysis of chimeric mice identified a role for Map2k4 in T cell cytokine production and proliferation. Map2k4-deficient chimeric mice frequently develop lymphadenopathy. MAP2K4 is altered in 1.97% of all human cancers.

This article is issued from Wikipedia. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.